By Mariam Sunny and Michael Erman Feb 13 (Reuters) - Moderna said it is looking for growth overseas after the U.S. FDA ...
Moderna will report its fourth-quarter 2025 earnings this morning in an investor call that’s taken on even more interest in ...
Moderna received a refusal-to-file letter from the FDA objecting to how it conducted a 40,000-person trial comparing its new ...
Presented by the Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care The Big Story FDA refuses ...
The flu vaccine is its first using mRNA technology for influenza.
Moderna said on Tuesday that the Food and Drug Administration (FDA) has refused to review its application for an mRNA flu ...
4don MSN
FDA blindsides Moderna with refusal to review flu vaccine application: ‘We’re pretty confused’
The Food and Drug Administration refused to review Moderna’s application for its new mRNA flu vaccine — a move the pharma ...
Mani Foroohar, M.D., of Leerink Partners, says that the decision reflects “how sharp the departure has been between the prior ...
Federal officials on Wednesday cast blame on Moderna as they stood by the Food and Drug Administration’s controversial ...
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine approvals.
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday ...
The US Food and Drug Administration has refused to accept an application from Moderna to review its first mRNA seasonal flu vaccine, the company said Tuesday, in another setback for the technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results